Tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate
C27H46N4O6 — CID 159216706
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate
Tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate (PubChem CID 159216706) has the molecular formula C27H46N4O6 and a molecular weight of 522.69 g/mol. Its IUPAC name is tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate |
|---|---|
| PubChem CID | 159216706 |
| Molecular Formula | C27H46N4O6 |
| Molecular Weight | 522.69 g/mol |
| Exact Mass | 522.34 |
| IUPAC Name | tert-butyl N-[(4-benzylmorpholin-2-yl)methyl]carbamate;tert-butyl N-(morpholin-2-ylmethyl)carbamate |
| SMILES | CC(C)(C)OC(=O)NCC1CN(Cc2ccccc2)CCO1.CC(C)(C)OC(=O)NCC1CNCCO1 |
| InChI | InChI=1S/C17H26N2O3.C10H20N2O3/c1-17(2,3)22-16(20)18-11-15-13-19(9-10-21-15)12-14-7-5-4-6-8-14;1-10(2,3)15-9(13)12-7-8-6-11-4-5-14-8/h4-8,15H,9-13H2,1-3H3,(H,18,20);8,11H,4-7H2,1-3H3,(H,12,13) |
| InChIKey | KRDXYFMMWYDLKC-UHFFFAOYSA-N |
| XLogP | 2.91 |
| TPSA | 110.39 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 522.69 |
| LogP ≤ 5 | 2.91 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159216706 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.